Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.24B |
| 2 |
Apple
AAPL
|
+$1.14B |
| 3 |
Tesla
TSLA
|
+$1.05B |
| 4 |
Shopify
SHOP
|
+$1B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$901M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.13B |
| 2 |
Netflix
NFLX
|
+$1.1B |
| 3 |
NVO
Novo Nordisk
NVO
|
+$1.03B |
| 4 |
Eli Lilly
LLY
|
+$931M |
| 5 |
Trade Desk
TTD
|
+$899M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.77% |
| 2 | Communication Services | 17.54% |
| 3 | Consumer Discretionary | 14.14% |
| 4 | Healthcare | 7% |
| 5 | Financials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Frontdoor
FTDR
$5.38B
| – | – |
-17,831
| Closed | -$1.05M |
|
602
Fortive
FTV
$18.4B
| – | – |
-386,836
| Closed | -$20.2M |
|
603
Grid Dynamics Holdings
GDYN
$617M
| – | – |
-1,966,828
| Closed | -$22.7M |
|
604
Galicia Financial Group
GGAL
$7.79B
| – | – |
-683,645
| Closed | -$34.4M |
|
605
GitLab
GTLB
$6.13B
| – | – |
-16,510
| Closed | -$745K |
|
606
Halozyme
HALO
$9.93B
| – | – |
-11,190
| Closed | -$582K |
|
607
Herc Holdings
HRI
$5.67B
| – | – |
-249,388
| Closed | -$32.8M |
|
608
ICICI Bank
IBN
$109B
| – | – |
-300,927
| Closed | -$10.1M |
|
609
Inspire Medical Systems
INSP
$1.74B
| – | – |
-45,439
| Closed | -$5.9M |
|
610
Intel
INTC
$513B
| – | – |
-502,856
| Closed | -$11.3M |
|
611
Gartner
IT
$12.5B
| – | – |
-7,274
| Closed | -$2.94M |
|
|
OPLN
612
Openlane
OPLN
$4.11B
| – | – |
-42,903
| Closed | -$1.05M |
|
|
KW
613
DELISTED
Kennedy-Wilson Holdings
KW
| – | – |
-118,510
| Closed | -$806K |
|
614
Lantheus
LNTH
$6.6B
| – | – |
-5,776
| Closed | -$473K |
|
615
Life Time Group Holdings
LTH
$10B
| – | – |
-15,558
| Closed | -$472K |
|
616
Matsons
MATX
$6.32B
| – | – |
-8,485
| Closed | -$945K |
|
617
Mueller Industries
MLI
$15.2B
| – | – |
-33,954
| Closed | -$1.35M |
|
618
MoonLake Immunotherapeutics
MLTX
$1.51B
| – | – |
-62,318
| Closed | -$2.94M |
|
|
MRC
619
DELISTED
MRC Global
MRC
| – | – |
-77,316
| Closed | -$1.06M |
|
620
Marvell Technology
MRVL
$192B
| – | – |
-32,866
| Closed | -$2.54M |
|
|
NEE.PRR
621
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| – | – |
-15,911
| Closed | -$632K |
|
622
NeoGenomics
NEO
$2.06B
| – | – |
-1,663,905
| Closed | -$12.2M |
|
623
NMI Holdings
NMIH
$3.35B
| – | – |
-14,581
| Closed | -$615K |
|
624
Northern Oil and Gas
NOG
$2.17B
| – | – |
-924,629
| Closed | -$26.2M |
|
625
NovoCure
NVCR
$1.87B
| – | – |
-29,010
| Closed | -$516K |
|
Similar funds
Jennison Associates's Q3 2025 Portfolio in Review
As of Q3 2025, Jennison Associates held 667 positions worth $172B, up 1.9% from $169B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Jennison Associates withdrew a net $8.14B in Q3 2025, closing 107 positions and reducing 253 holdings. Its most notable exit was Fair Isaac, an estimated $172M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $627M.
- Jennison Associates's largest Q3 2025 buy was Advanced Micro Devices: 3,874,319 shares worth $627M.
- Jennison Associates added most to Oracle in Q3 2025, an estimated $2.24B increase.
- Jennison Associates's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $1.13B.
- Jennison Associates fully exited Fair Isaac in Q3 2025, selling an estimated $172M.
- Jennison Associates's ten largest holdings make up 47% of its $172B portfolio in Q3 2025.
- Jennison Associates opened 93 new positions and closed 107 in Q3 2025.
- Jennison Associates's portfolio value rose 1.9% quarter-over-quarter to $172B.
Based on Jennison Associates's 13F filing for Q3 2025, filed 30 Oct 2025.